C07D 491/044
With only one oxygen atom as ring hetero atom in the oxygen-containing
Official title: with only one oxygen atom as ring hetero atom in the oxygen-containing ring
C07D491/044 (With only one oxygen atom as ring hetero atom in the oxygen-containing) appears on 2,083 US grants and 3,311 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,083
- Published applications
- 3,311
- Assignees
- 1,124
- Inventors
- 8,916
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 9 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 3 | 3 |
| 2003 | 3 | 4 |
| 2004 | 2 | 6 |
| 2005 | 0 | 13 |
| 2006 | 7 | 20 |
| 2007 | 6 | 33 |
| 2008 | 15 | 41 |
| 2009 | 19 | 56 |
| 2010 | 30 | 76 |
| 2011 | 40 | 99 |
| 2012 | 65 | 105 |
| 2013 | 92 | 141 |
| 2014 | 98 | 162 |
| 2015 | 122 | 172 |
| 2016 | 120 | 200 |
| 2017 | 151 | 183 |
| 2018 | 149 | 196 |
| 2019 | 157 | 190 |
| 2020 | 143 | 254 |
| 2021 | 148 | 183 |
| 2022 | 142 | 197 |
| 2023 | 143 | 296 |
| 2024 | 140 | 272 |
| 2025 | 160 | 243 |
| 2026 | 96 | 166 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Organic compound, light-emitting device, light-emitting apparatus, electronic appliance, and lighting device6 Oct 2026US 12,753,182 B2Semiconductor Energy Laboratory Co.Ltd.
- 1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases6 Oct 2026US 12,753,183 B2University of Puerto Rico
- P38alpha mitogen-activated protein kinase inhibitors6 Oct 2026US 12,753,184 B2Gen1E Lifesciences Inc.
- Organic molecules for use in light-emitting devices29 Sep 2026US 12,747,210 B2Samsung Display Co., Ltd.
- EIF4A-inhibiting compounds and methods related thereto29 Sep 2026US 12,747,249 B2SJP Biotec GmbH
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Crystalline forms of a parp1 inhibitor8 Oct 2026US 2026/0308163 A1Gilead Sciences, Inc.
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Brm selective degradation agent and use thereof8 Oct 2026US 2026/0308165 A1
- Oxadiazolyl dihydropyrano[2,3-b]pyridine inhibitors of hipk2 for treating kidney fibrosis8 Oct 2026US 2026/0308166 A1Icahn School of Medicine at Mount Sinai
Most cited
By later US patents
- N-(hetero)aryl-pyrrolidine derivatives of pyrazol-4-yl-pyrrolo[2,3-d]pyrimidines and pyrrol-3-yl-pyrrolo[2,3-d]pyrimidines as janus kinase inhibitors110US 8,716,303 B2Incyte Corporation · 2014
- Novobiocin analogues as neuroprotective agents and in the treatment of autoimmune disorders107US 7,622,451 B2University of Kansas · 2009
- Heteroaryl derivatives as CFTR modulators94US 8,299,099 B2Vertex Pharmaceuticals Incorporated · 2012
- Complement pathway modulators and uses thereof90US 9,056,874 B2Novartis AG · 2015
- AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases80US 7,560,434 B2BioCryst Pharmaceuticals, Inc. · 2009